Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | I-8-069 |
Topic: | Immunizations |
Section: | Injections |
Effective Date: | July 1, 2018 |
Issue Date: | July 2, 2018 |
Last Reviewed: | May 2017 |
Patient Protection and Affordable Care Act, as amended (PPACA) (Enacted 3/23/2010) Refer to the current year’s Preventive Schedule for guidelines on the Provider Resource Center for when and how often the following immunizations are recommended. This schedule is a reference tool for planning preventive care, and lists items/services required under the Patient Protection and Affordable Care Act of 2010 (PPACA), as amended. It is reviewed and updated periodically based on the advice of the U.S. Preventive Services Task Force, laws and regulations and updates to clinical guidelines established by national medical organizations. Accordingly, the content of this schedule is subject to change. Specific needs for preventive immunizations may vary according to member’s personal risk factors. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
The following mandated immunizations are covered for the insured or the insured spouse who are greater than or equal to 21 years of age, or a dependent child in accordance with the age limits of the individual contracts:
Other Non-Mandated Immunizations
Other than those specific childhood immunizations listed above, coverage for immunizations is determined according to individual or group customer benefits. Immunizations should be reported under the appropriate procedure code. Immunization is acceptable for the following diseases:
Immunizations or injections for diseases other than those listed above are not eligible for payment. Immunizations must be FDA approved to be eligible for payment.
The cholera vaccine (procedure code 90625) is not FDA approved and, therefore, is non-covered.
|
The policy position applies to all commercial lines of business |
Denial Statements |
A network provider can bill the member for the non-covered service.
Links |
06/2017, Coverage for the Quadrivalent (RIV) Influenza Virus Vaccine
03/2018, Coverage for the Shingles Vaccine Shingrix